Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20200610003
TCTR20200610003
Terminated
Phase 3

A Randomized Controlled Trial of Comparative Efficacy between Sodium Bicarbonate and Heparin as A Locking Solution for Tunneled Central Venous Catheters Among Patients Requiring Maintenance Hemodialysis

Grant for research, Faculty of medicine, Chulalongkorn university0 sites118 target enrollmentJune 10, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCatheter loss due to CRT or CRBSICatheter lockCatheter related blood stream infectionCatheter related thrombosisEnd stage renal diseaseSodium bicarbonateHeparin

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Catheter loss due to CRT or CRBSI
Sponsor
Grant for research, Faculty of medicine, Chulalongkorn university
Enrollment
118
Status
Terminated
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

The present study was stopped early due to an excess of catheter related thrombosis in the sodium bicarbonate group. From the first 6 weeks of follow-up, there were no catheter losses due to CRT or CRBSI in both groups. The sodium bicarbonate group had a significantly higher rate of the secondary composite outcomes and this was entirely caused by CRT with the median time to thrombosis of 23.6 days.

Registry
who.int
Start Date
June 10, 2020
End Date
June 30, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Grant for research, Faculty of medicine, Chulalongkorn university

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients age more than 18 years old
  • •2\. Patients with maintenance chronic hemodialysis at least 2 sessions per week
  • •3\. Patients with permanent catheter as vascular access for hemodialysis

Exclusion Criteria

  • •1\. Catheter dysfunction at baseline
  • •2\. On current anticoagulation therapy
  • •3\. Patients with known coagulopathy or hemophilia
  • •4\. Patients with cirrhosis Child\-Pugh B or C
  • •5\. Patients with thrombocytopenia less than 100,000 u/L
  • •6\. Patients with central vessel stenosis and vena cava syndrome, previously documented.
  • •7\. Patients with heparin\-induced thrombocytopenia
  • •8\. Patients with unstable condition within 1 month before enrollment
  • •9\. Patients with expected life expectancy less than 6 month

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 2
A Phase 2 Study to Evaluate the Safety and Tolerability of IMR-687 in Subjects with Beta ThalassemiaBeta Thalassemiainherited blood disorder10038158
NL-OMON54921IMARA, Inc.15
Completed
Not Applicable
A prospective, multicenter clinical study to evaluate the safety profile of the FlexiSurge Adhesion Barrier for the prevention of intra-abdominal adhesion formation after laparotomyvorming van adhesies na buikchirurgieadhesion formationpostoperative adhesions
NL-OMON40303Medisse BV5
Completed
Phase 2
A Study of Rilematovir (JNJ-53718678) in Adult Outpatients with Respiratory Syncytial Virus (RSV) Infectio
JPRN-jRCT2031210527akama Takahiro5
Completed
Not Applicable
A prospective clinical follow up study with a New Press-fit Cup with initial RSA analysis (NPC).Osteoarthritisworn hip10023213
NL-OMON46964Stichting SCORE28
Completed
Not Applicable
A two-part parallel group study to assess the safety, tolerability and pharmacokinetic (PK) profile of multiple oral doses of RDN-929 in healthy older adults and subjects with early symptomatic Alzheimer*s DiseaseAlzheimer's Diseaseneurodegenerative diseases
NL-OMON48424Rodin Therapeutics, Inc.45